back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-11-17 09:37 Tx date 2023-11-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-145,000
-100,000 vol $1.45 each |
484,857 | |
| Filed 2023-08-18 11:56 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,900 vol |
5,900 | |
| Filed 2023-08-18 11:55 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,891
+21,700 vol $2.76 each |
584,857 | |
| Filed 2022-12-13 12:32 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
563,157 | |
| Filed 2022-03-09 10:09 Tx date 2022-03-09 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-109,193.76
-14,736 vol $7.41 each |
483,157 | |
| Filed 2021-12-13 17:35 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
497,893 | |
| Filed 2021-03-12 18:09 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$289,000
+85,000 vol $3.40 each |
442,893 | |
| Filed 2020-12-16 17:01 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$634,000
+200,000 vol $3.17 each |
357,893 | |
| Filed 2020-07-07 10:35 Tx date 2020-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,210 vol |
10,315 | |
| Filed 2020-07-07 10:34 Tx date 2020-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,210 vol |
0 | |
| Filed 2020-03-09 10:21 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
157,893 | |
| Filed 2019-12-18 15:39 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
||
| Filed 2019-12-18 15:39 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
157,893 | |
| Filed 2019-07-03 13:53 Tx date 2019-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,105 vol |
6,105 | |
| Filed 2019-07-03 13:51 Tx date 2019-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,105 vol |
4,210 | |
| Filed 2018-12-18 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-237,107 vol |
27,893 | |
| Filed 2018-12-18 Tx date 2018-12-14 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$81,900
+30,000 vol $2.73 each |
57,893 | |
| Filed 2018-12-18 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-53,685 vol |
6,315 | |
| Filed 2018-12-12 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-12 Tx date 2018-12-11 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,389
+4,000 vol $2.10 each |
4,000 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$109,200
+140,000 vol $0.78 each |
265,000 | |
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+60,000 vol |
60,000 | |
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,000
+125,000 vol $0.52 each |
125,000 |